Benefit of a Short Chain Peptide as a Targeting Ligand of Nanocarriers for a Brain-Driven Purpose

Treatment of glioma remains a critical challenge worldwide, since the therapeutic effect is greatly hindered by poor transportation across the blood brain barrier (BBB) and low penetration into tumor cells. In this study, a peptide-conjugated nano-delivery system was explored for the purpose of glio...

Full description

Saved in:
Bibliographic Details
Published inPharmaceutics Vol. 13; no. 8; p. 1249
Main Authors Lo, Yu-Chen, Lin, Wen-Jen
Format Journal Article
LanguageEnglish
Published Basel MDPI AG 12.08.2021
MDPI
Subjects
Online AccessGet full text

Cover

Loading…